BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.

Beijing Bohui Innovation Biotechnology Group Co., Ltd.

300318

CNE000001QR4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
4.67 ^CNY	+0.86%		-7.71%	-25.16%

2023	Bohui Innovation Biotechnology Secures Blood Collection License in China’s Yunnan Province	MT
2023	Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index

September 20, 2021 at 12:00 am EDT

Latest news about Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Bohui Innovation Biotechnology Secures Blood Collection License in China’s Yunnan Province	Nov. 23	MT
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index	23-09-18	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Announces Board and Executive Changes	23-06-30	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Bohui Innovation Biotech Unit Gets Operation Permit for Plasma Center	23-02-03	MT
Beijing Bohui Innovation Biotech Unit Sells Land for 108.2 Million Yuan	22-12-28	MT
Bohui Innovation Biotechnology Unit to Sell Land-Use Rights For 108 Million Yuan; Shares Fall Nearly 4%	22-12-27	MT
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) dropped from S&P Global BMI Index	22-12-19	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index	21-09-20	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. cancelled the transaction announced on February 17, 2020	21-09-05	CI
Beijing Bohui Innovation Biotechnology Co., Ltd. cancelled the acquisition of 100% stake in Adchim SAS from Zhuhai Aosen Investment Co., Ltd.	21-09-05	CI
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Beijing Bohui Innovation Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-26	CI
Beijing Bohui Innovation Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-26	CI
Beijing Bohui Innovation Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-26	CI
Changzhou Linghang Quantum Biomedical Technology Co., Ltd. announced that it has received CNY 25 million in funding from Beijing Bohui Innovation Biotechnology Co., Ltd.	20-10-19	CI
Changzhou Linghang Quantum Biomedical Technology Co., Ltd. announced that it expects to receive CNY 25 million in funding from Beijing Bohui Innovation Biotechnology Co., Ltd.	20-09-11	CI

Chart Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Duration

Period

Chart Beijing Bohui Innovation Biotechnology Group Co., Ltd.

More charts

Beijing Bohui Innovation Biotechnology Group Co Ltd, formerly Beijing Bohui Innovation Biotechnology Co Ltd, is a China-based company mainly engaged in inspection and testing business and blood products business. The Company operates two major reporting segments. The Inspection and Testing segment is mainly engaged in the research and development, production and sales of inspection instruments and inspection reagents. The Company's products for medical institutions mainly involve in vitro diagnostic testing, including human trace element testing and human papillomavirus (HPV) testing. The Company's testing equipment for non-medical institutions is mainly small mass spectrometers and related products. The Biological Products segment is mainly blood products, which can be divided into products such as albumin, immunoglobulin, coagulation factors and vaccines. The Company distributes its products within the domestic market and to overseas market.

Sector

Pharmaceuticals

Calendar

2024-04-25 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.	-25.16%	526M
CSL LIMITED	-2.86%	87.31B
SAMSUNG BIOLOGICS CO.,LTD.	+3.95%	40.86B
BIOGEN INC.	-21.94%	29.36B
UCB	+56.46%	24.49B
BIOMARIN PHARMACEUTICAL INC.	-5.41%	17.31B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44.23%	11.26B
INCYTE CORPORATION	-17.60%	11.62B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13.96%	11.31B
SWEDISH ORPHAN BIOVITRUM AB	+6.44%	8.31B

Biopharmaceuticals